The impact of functioning pancreas-kidney transplantation and pancreas alone transplantation on the lipid metabolism of statin-naïve diabetic patients

Clinical Transplantation

Volumn 23, Issue 2, 2009, Pages 199-205

  Lauria, Márcio W ^a,b   Figueiró, José Maria ^b   Machado, Lucas José Campos ^a   Sanches, Marcelo D ^a   Lana, Ângela Maria Quintão ^a   de Oliveira Jr , Antônio Ribeiro ^a,c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b HOSPITAL FELÍCIO ROCHO   (Brazil)

^c NONE   (Brazil)

Author keywords

Diabetes; Kidney pancreas transplantation; Lipids; Pancreas transplantation; Pancreas transplantation alone

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HEMODIALYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; KIDNEY PANCREAS TRANSPLANTATION; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTICHOLESTEREMIC AGENTS; DIABETES MELLITUS, TYPE 1; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIPIDS; MALE; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; TACROLIMUS;

EID: 64349098032     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.00969.x     Document Type: Article

References (32)

1. Larsen JL. Pancreas transplantation-indications and consequences. Endocr Rev 2004: 25: 919.
2. Biesenbach G, Margreiter R, Konigsrainer A et al. Comparison of progression of macrovascular diseases after kidney or pancreas and kidney transplantation in diabetic patients with end-stage renal disease. Diabetologia 2000: 43: 231.
3. Luan FL, Miles CD, Cibrik DM et al. Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type I diabetes mellitus. Transplantation 2007: 84: 541.
4. Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002: 2: 807.
5. Lauria MW, Figueiró JM, Rodrigues LF et al. Increased 72 hour mean glucose concentration measured by continuous glucose monitoring system in normal glucose tolerant patients with pancreas transplantation. Diabetes 2007:56 (Suppl. 1): A519.
6. Gruessner AC, Sutherland DER. Transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Registry (IPTR) as of june 2004. Clin Transplant 2005: 19: 433.
7. Mai ML, Ahsan N, Gonwas T. The long-term management of pancreas transplantation. Transplantation 2006: 82: 991.
8. Larsen JL, Stratta RJ, Miller S et al. Lipid status after pancreas kidney transplantation. Diabetes Care 1992: 15: 35.
9. Davidson J, Wilkinson AH, Dantal J et al. New-onset diabetes after transplantation: 2003 International Consensus Guidelines. Transplantation 2003: 7: S3.
10. Friedewald WT, Levy RI, Fredickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972: 18: 499.
11. National Cholesterol Education Program Expert Panel On Detection. Evaluation and treatment of high blood cholesterol in adults - adult treatment panel III. Circulation 2002: 106: 3143.
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976: 16: 31.
13. Joint National Committee On Prevention. Detection, evaluation and treatment of high blood pressure - the seventh report. Hypertension 2003: 42: 1206.
14. Henley SA, Akhter J, Stratta RJ et al. Lipids increase after solitary pancreas transplantation. Diabetes Care 1999: 22: 320.
15. Schimed BM, Muller SA, Mehrabi A et al. Immunosuppressive standards in simultaneous kidney-pancreas transplantation. Clin Transplant 2006: 20 (suppl. 17): 44.
16. Vincenti F, Friman S, Scheuermann E et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007: 7: 1506.
17. Fiorina P, La Rocca E, Venturini M et al. Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes 2001: 50: 496.
18. Burke GW, Alejandro R, Roth D et al. Use of FK506 in simultaneous pancreas-kidney transplantation: Lack of impairment of glycemic or lipid metabolism. Transplant Proc 1995: 27: 3119.
19. Sudan D, Sudan R, Stratta R. Long-term outcome of simultaneous kidney-pancreas transplantation. Transplantation 2000: 69: 550.
20. Nankivell BJ, Lau SG, Chapman JR et al. Progression of macrovascular disease after transplantation. Transplantation 2000: 69: 74.
21. Mccauley J, Shapiro R, Jordan ML et al. Long-term lipid metabolism in combined kidney-pancreas transplant recipients under tacrolimus immunosuppression. Transplant Proc 2001: 33: 1698.
22. Tamajón LP, Miranda DM, Figueroa AC et.al. Improved cardiovascular risk profile of patients with type I diabetes and renal failure after simultaneous pancreas-kidney transplantation. Transplant Proc 2005: 37: 3979.
23. Cuy Y, Blumenthal RS, Flaws JA et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001: 161: 1413.
24. Abate N, Veja GL, Grundy SM. Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100. Atherosclerosis 1993: 104: 159.
25. Nordén G, Carlstrom J, Wramner L, Gudrun N. Macrovascular disease after simultaneous pancreas and kidney transplantation. Clin Transplant 2004: 18: 372.
26. Sutherland DER, Gruessner RW, Dunn DL et al. Lessions learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001: 233: 463.
27. Donahoo WT, Kosmiski LA, Eckel RH. Drugs causing dyslipoproteinemia. Endocrinol Metab Clin North Am 1998: 27: 677.
28. Coppelli A, Giannarelli R, Mariotti R et al. Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type I diabetic patients. Transplantation 2003: 76: 974.
29. Boggi U, Mosca F, Vistoli F et al. Ninety-five percent insulin independence rate 3 years after pancreas transplantation alone with portal-enteric drainage. Transplant Proc 2005: 37: 1274.
30. Coppelli A, Giannarelli R, Vistoli F et al. The beneficial effects of pancreas transplant alone on diabetic nephropathy. Diabetes Care 2005: 28: 1366.
31. Venstron JM, Mcbride MA, Rother KI et al. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003: 290: 2817.
32. Gruessner RW, Sutherland DE, Gruessner AC. Mortality assessment for pancreas transplants. Am J Transplant 2004: 4: 2018.